"Masimo secures FDA approval for OIRD detection on wearable patient monitor" was originally created and published by Medical ...
The OIRD detection capability [Image courtesy of Masimo] Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform.
GOOD AFTERNOON. ON THIS DAY TEN YEARS AGO, HATE HIT ORLANDO 49 SOULS TAKEN FROM US. OUR CITY SHELL SHOCKED THE SCENE ONCE A PLACE OF JOY IS NO MORE. BUT THE MEMORIES OF THE HAPPINESS AND THE TRAGEDY ...
In Ezekiel 9, the prophet receives a vision of God's judgment on Jerusalem. Six men with slaughter weapons come to punish the city, but one man with a writing case receives a special command. Verse 4 ...
In January, Medtronic published the results of a verification study of its new processor. Used across the full range of skin tones, the technology, Nell-EQ, achieved better oxygen saturation accuracy ...
The Nellcor pulse oximeter [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced today that it received FDA 510(k) clearance for its Nellcor pulse oximetry system with the Nell-EQ intelligent ...
May 2026 was one of the busiest months in the history of continuous glucose monitoring. Within less than 30 days, four new sensor platforms were launched, previewed or received regulatory approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results